Please assess the completion status of the following clinical trial:

Trial Title: PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Subject who received the enough study information and signed informed consent form.~2. Subject who had chronic low back pain accompanying with lower limb pain from the knee to the ankle.~3. Subject is male or female patient ≥18 years old.~4. Subject who has complained low back pain for 3 months or more before Visit 1.~5. Subject who is refractory to prior analgesics for 3 months and more.~6. Subject who is able and willing to complete all study related assessment and comply with the study schedule and clinical procedures at clinic.~7. Subject whose pain Numeric Rating Scale(NRS) ≥ 5 at baseline (based on recall over the past week)~Exclusion Criteria:~1. Subject who, in the opinion of the investigator, was not likely to complete the trial for whatever reason.~2. Subject who has been already treated by pregabalin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pregabalin (Type: None): Patients will be treated for 8 weeks with pregabalin in primary care: no intervention
- Usual care (Type: None): Patients will be treated for 8 weeks with other analgesics in usual care: no intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).